Bertrand Guignard

644 total citations
30 papers, 428 citations indexed

About

Bertrand Guignard is a scholar working on Geriatrics and Gerontology, Pediatrics, Perinatology and Child Health and Toxicology. According to data from OpenAlex, Bertrand Guignard has authored 30 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Geriatrics and Gerontology, 9 papers in Pediatrics, Perinatology and Child Health and 7 papers in Toxicology. Recurrent topics in Bertrand Guignard's work include Pharmaceutical Practices and Patient Outcomes (19 papers), Pharmaceutical studies and practices (8 papers) and Pharmacovigilance and Adverse Drug Reactions (7 papers). Bertrand Guignard is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (19 papers), Pharmaceutical studies and practices (8 papers) and Pharmacovigilance and Adverse Drug Reactions (7 papers). Bertrand Guignard collaborates with scholars based in Switzerland, United States and United Kingdom. Bertrand Guignard's co-authors include Philippe Moreillon, Pascal Bonnabry, José M. Entenza, Caroline Samer, Jules Desmeules, Arnaud Perrier, Caroline Fonzo‐Christe, Pierre Dayer, Marisa Haenni and Pierre Olivier Lang and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of the American Geriatrics Society and British Journal of Anaesthesia.

In The Last Decade

Bertrand Guignard

29 papers receiving 413 citations

Peers

Bertrand Guignard
Gurumurthy Parthasarathi India
E. Salas Spain
Olivia Ferrández Spain
Olayinka O. Ogunleye Nigeria
Roy Guharoy United States
Amanda Wilmer Canada
James C. Garrelts United States
Evelyn Deasy Ireland
L. Foroni France
Tsegaye Melaku Ethiopia
Gurumurthy Parthasarathi India
Bertrand Guignard
Citations per year, relative to Bertrand Guignard Bertrand Guignard (= 1×) peers Gurumurthy Parthasarathi

Countries citing papers authored by Bertrand Guignard

Since Specialization
Citations

This map shows the geographic impact of Bertrand Guignard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertrand Guignard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertrand Guignard more than expected).

Fields of papers citing papers by Bertrand Guignard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bertrand Guignard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertrand Guignard. The network helps show where Bertrand Guignard may publish in the future.

Co-authorship network of co-authors of Bertrand Guignard

This figure shows the co-authorship network connecting the top 25 collaborators of Bertrand Guignard. A scholar is included among the top collaborators of Bertrand Guignard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bertrand Guignard. Bertrand Guignard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guignard, Bertrand, et al.. (2024). A graphical model to make explicit pharmacist clinical reasoning during medication review. Research in Social and Administrative Pharmacy. 20(12). 1142–1150.
2.
Fonzo‐Christe, Caroline, et al.. (2024). Financial impact of medication reviews by clinical pharmacists to reduce in-hospital adverse drug events: a return-on-investment analysis. International Journal of Clinical Pharmacy. 46(2). 496–505. 11 indexed citations
3.
Blondon, Katherine, Élisabeth Van Gessel, Bernard Cerutti, et al.. (2022). Patients’ perceptions of conflicting information on chronic medications: a prospective survey in Switzerland. BMJ Open. 12(11). e060083–e060083. 3 indexed citations
4.
Grosgurin, Olivier, Christophe Marti, Caroline Samer, et al.. (2022). Development and retrospective evaluation of a clinical decision support system for the efficient detection of drug-related problems by clinical pharmacists. International Journal of Clinical Pharmacy. 45(2). 406–413. 9 indexed citations
5.
Reny, Jean‐Luc, Jérôme Stirnemann, Olivier Grosgurin, et al.. (2022). Development and assessment of PharmaCheck: an electronic screening tool for the prevention of twenty major adverse drug events. BMC Medical Informatics and Decision Making. 22(1). 146–146. 7 indexed citations
6.
Samer, Caroline, Jérôme Stirnemann, Olivier Grosgurin, et al.. (2021). Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-19. European Journal of Hospital Pharmacy. 30(2). 113–116. 6 indexed citations
7.
Guignard, Bertrand, Aude Desnoyer, Olivier Grosgurin, et al.. (2018). Prevention of potentially inappropriate medication in internal medicine patients: A prospective study using the electronic application PIM-Check. Journal of Clinical Pharmacy and Therapeutics. 43(6). 860–866. 12 indexed citations
8.
Desnoyer, Aude, Valérie Pourcher, Marie Besson, et al.. (2017). PIM-Check: development of an international prescription-screening checklist designed by a Delphi method for internal medicine patients. BMJ Open. 7(7). e016070–e016070. 27 indexed citations
9.
Boland, Benoît, et al.. (2016). Application of Beers and STOPP/START criteria: comparative impact on identification and relevance of potentially inappropriate prescriptions. Journal of the American Geriatrics Society. 64. 1 indexed citations
10.
Guignard, Bertrand, et al.. (2016). Muropeptide signature of inhibitors of protein synthesis correlates with β-lactam synergism against methicillin-resistant Staphylococcus aureus. International Journal of Antimicrobial Agents. 49(1). 53–61. 2 indexed citations
11.
Desnoyer, Aude, Bertrand Guignard, Pierre Olivier Lang, et al.. (2016). Prescriptions médicamenteuses potentiellement inappropriées en gériatrie : quels outils utiliser pour les détecter ?. La Presse Médicale. 45(11). 957–970. 15 indexed citations
12.
Lang, Pierre Olivier, Moustapha Dramé, Bertrand Guignard, et al.. (2015). Les critères STOPP/START.v2 : adaptation en langue française. NPG. Neurologie, psychiatrie, gériatrie/NPG. 15(90). 323–336. 27 indexed citations
13.
Guignard, Bertrand, Pascal Bonnabry, Arnaud Perrier, et al.. (2015). Drug-related problems identification in general internal medicine: The impact and role of the clinical pharmacist and pharmacologist. European Journal of Internal Medicine. 26(6). 399–406. 61 indexed citations
14.
Fonzo‐Christe, Caroline, Bertrand Guignard, Klara M. Posfay‐Barbe, et al.. (2014). Impact of Clinical Decision Support Guidelines on Therapeutic Drug Monitoring of Gentamicin in Newborns. Therapeutic Drug Monitoring. 36(5). 656–662. 7 indexed citations
15.
Guignard, Bertrand, Jacques Vouillamoz, Marlyse Giddey, & Philippe Moreillon. (2013). A positive interaction between inhibitors of protein synthesis and cefepime in the fight against methicillin-resistant Staphylococcus aureus. European Journal of Clinical Microbiology & Infectious Diseases. 32(7). 899–907. 10 indexed citations
16.
Lorenzini, Kuntheavy Ing, Caroline Samer, Bertrand Guignard, et al.. (2012). Quel programme informatique de détection des interactions médicamenteuses néfastes. Revue Médicale Suisse. 8(358). 3 indexed citations
17.
Lorenzini, Kuntheavy Ing, Caroline Samer, Pierre Dayer, et al.. (2012). Quel programme [b]informatique[/b] de détection des interactions médicamenteuses néfastes ?. Revue Médicale Suisse. 8(358). 1978–1982. 1 indexed citations
18.
Guignard, Bertrand, et al.. (2010). Evaluation of tools to prevent drug incompatibilities in paediatric and neonatal intensive care units. Pharmacy World & Science. 32(4). 520–529. 28 indexed citations
19.
Guignard, Bertrand, et al.. (2008). Practical evaluation of the drug-related problem management process in Swiss community pharmacies. Pharmacy World & Science. 30(6). 777–786. 29 indexed citations
20.
Guignard, Bertrand, José M. Entenza, & Philippe Moreillon. (2005). β-lactams against methicillin-resistant. Current Opinion in Pharmacology. 5(5). 479–489. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gurumurthy Parthasarathi Breakdown of academic impact, for papers by E. Salas Breakdown of academic impact, for papers by Olivia Ferrández Breakdown of academic impact, for papers by Olayinka O. Ogunleye Breakdown of academic impact, for papers by Roy Guharoy Breakdown of academic impact, for papers by Amanda Wilmer Breakdown of academic impact, for papers by James C. Garrelts Breakdown of academic impact, for papers by Evelyn Deasy Breakdown of academic impact, for papers by L. Foroni Breakdown of academic impact, for papers by Tsegaye Melaku
Rankless by CCL
2026